Background Previous models of Hospital at Home (HAH) for COPD exacerbation (ECOPD ... but the effect on cost and outcome is unknown. Eligibility criteria included low mortality risk (DECAF 0–1), age ...

May 9 (UPI) --Smoking can't explain why women are more at risk for COPD, a new study says. Women are about 50% more likely than men to develop COPD even though they are less likely to smoke ...

Chronic bronchitis is a common disease in elderly patients. Acute exacerbation of chronic bronchitis (AECB) is a common feature of chronic obstructive pulmonary disease. Antibiotic therapy based ...

Asthma–chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) is a commonly encountered yet loosely defined clinical entity. ACOS accounts for approximately 15–25% of the ...

These monitors track metrics like respiratory rate, depth of breathing, and even subtle wheezing sounds that might precede a full-blown asthma attack or COPD exacerbation. The preventive potential ...

Verona Pharma has agreed a new $400 million debt facility with Oxford Finance and Hercules Capital designed to help the company navigate the possible approval and launch of ensifentrine, its ...

Ogun State Governor Dapo Abiodun, on Friday, inaugurated Nigeria’s first large-scale rapid diagnostic test (RDT) production facility, CODIX BIO Limited, aimed at strengthening local healthcare ...

Speaking to CNA, two representatives said DAS acknowledged the "good number" of students who do not meet the diagnostic criteria for dyslexia but who have similar learning challenges. "This group ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

The proportion of adult managed care organizations with availability varied from 24 to 100% for SGLT2 inhibitors and 0 to 99% for GLP-1 receptor agonists. HealthDay News — Many Medicaid enrollees with ...

Suraksha Diagnostic Ltd. share price moved up by 0.73% from its previous close of Rs 291.05. Suraksha Diagnostic Ltd. stock last traded price is 293.15 ...